<DOC>
	<DOCNO>NCT01148446</DOCNO>
	<brief_summary>The study purpose compare R-CHOP versus R-mini-CEOP elderly patient ( &gt; 65 year ) Diffuse Large B Cell Lymphoma ( DLBCL ) .</brief_summary>
	<brief_title>R-CHOP Versus R-mini-CEOP Elderly Patients ( &gt; 65 ) With DLBCL</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>1 . Patients untreated DLBCL age 66 80 year without major accompany disease consider `` non frail '' . 2 . Patients classify `` non frail '' ( fit ) ADL ( Activity Daily Living ) score 6 less three grade 3 Cumulative Illness Rating Score Geriatrics ( CIRSG ) comorbidities grade 4 comorbidities absence geriatric syndrome 3 . Patients HIV negativity ; 4 . Concurrent malignancy ; 5 . Written Informed Consent . All patient classify `` unfit '' , exclude randomization</criteria>
	<gender>All</gender>
	<minimum_age>66 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>DLBCL</keyword>
	<keyword>R-CHOP</keyword>
	<keyword>R-CEOP</keyword>
	<keyword>Elderly patient</keyword>
</DOC>